chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in whole body in the same places she has arthritis after 1st dose/Patient had arthritis in her body everywhere; Bladder burn after 1st shot; This spontaneous case was reported by a consumer and describes the occurrence of BLADDER PAIN (Bladder burn after 1st shot) and ARTHRITIS (Pain in whole body in the same places she has arthritis after 1st dose/Patient had arthritis in her body everywhere) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031mzua) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included RIVAROXABAN (XARELTO), DILTIAZEM, AMLODIPINE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and BIOTIN for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced BLADDER PAIN (Bladder burn after 1st shot). On 24-Feb-2021, the patient experienced ARTHRITIS (Pain in whole body in the same places she has arthritis after 1st dose/Patient had arthritis in her body everywhere). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 28-Feb-2021, BLADDER PAIN (Bladder burn after 1st shot) and ARTHRITIS (Pain in whole body in the same places she has arthritis after 1st dose/Patient had arthritis in her body everywhere) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took Tylenol for the pain. Antibiotic was also used as treatment medication.   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Follow up received on 06-APR-2021.Significant follow up appended.Event verbatim term was updated(Pain in whole body in the same places as she has arthritis after 1st dose was changed to Patient had arthritis in her body every where).An additional contact number is also included.
p/ pt recv vax approx 2yrs later pt exp ``early but typical chickenpox''
Patient received first dose of Moderna vaccine on 8.6.2021. Patient states he has had an on and off headache for 6 days. Doesn't describe as severe, just annoying.
Patient came in complaining of flu symptoms, such as dry heaves, aches, nausea and dizziness.
Covid test name post vaccination: PRC, Covid test result: Positive; Covid test name post vaccination: PRC, Covid test result: Positive; Headache; Stiffness; Soreness in neck; Knees/Hips; Back; Insomnia; This is a spontaneous report from a contactable consumer. This consumer reported for a patient that:  A 37-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on Mar2021 (at the age of 37-years-old) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient received any other vaccines within 4 weeks prior to the COVID vaccine was unknown. Prior vaccination it was unknown and post vaccination, the patient was tested for COVID-19. On an unspecified date, the patient experienced covid test name post vaccination: prc, covid test result: positive (medically significant), headache, stiffness, soreness in neck, knees/hips, back, insomnia. The patient underwent lab tests and procedures which included PRC: positive on unspecified date. Case was reported as serious. It was unknown, if patient received treatment for the events except covid-19 event. The clinical outcome of events covid test name post vaccination: prc, covid test result: positive was unknown and other events were recovered with sequel on unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
- Sore arm at the injection site followed by severe lymph nodes inflammation (right armpit & near the breast  & throat/neck areas) - Followed by all right side joints inflammation; pain in right side wrist, shoulder rotator, hip, knee, & ankle - Noted bit of heart pain, increased heart burn at night and an inability to manage breathing while performing cardio exercises like running & bicycling - A month after the 2nd vaccine, right side hip inflammation/pain & breathing issues remain  - Did not need visit the doctor due to lack trust in the medical community for being truthful about the side effects of the vaccine.  Also, possibility of their lack of knowledge.
Heart attack; This is a spontaneous report from a contactable consumer (patient's husband) through a Pfizer sales representative. A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) as a single dose, with route of administration and therapy date unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, two weeks after vaccination, the patient had a heart attack. The outcome of the event was unknown. The patient's cardiologist called it a "mysterious case".  Information about lot/batch has been requested.
Narrative:  82yo male patient with end stage renal disease died on 10/22/21 at inpt hospice care (non-agency facility). Pt had received covid vaccines on 5/6/21 & 6/3/21. Death is not related to covid vaccines.
Patient reported to pharmacist that he keeps have a scab approximately the size of a pencil eraser that keeps forming where the vaccine was injected. Itching is also occurring near the injection site. This scab formation has been going on for more than 2 months. Patient says he has tried using some cream to help with irritation.
36 hours following shot: extreme soreness around the injection site, which then went away.  6 days after injection, the lymph nodes under my armpit in the arm I had the injection were swollen and hurt. 7 days after injection, the injection arm had extreme soreness (and continued lymph node pain). 8 days after injection, I had a 4 x 4 inch raised red rash around the injection site (hot to the touch, sore, and itchy). 9 days after injection, rash and soreness are starting to lessen.
Large red swollen area around shot site. About 60 mm induration. Very itchy. Tx cold/warm compress, ATARAX and MOTRIN
FEVER, COUGH SNEEZING, NUMB ARM FROM TOP TO ELBOW
Client woke up Saturday morning with pain, redness, and swelling in bilateral arms where vaccines were administered.
1st dose in 2018, yesterday received 2nd; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix, 4 years ago from reporting date, in 2018).   On 2nd March 2022, the patient received the 2nd dose of Shingrix. On 2nd March 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were reported as follows: The age at vaccination was not reported. The pharmacist reported that the patient received the second dose, later than the recommended interval, which led to lengthening of vaccination schedule. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. This case had been linked to US2022040255, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022040255:Same reporter.
According to patient on 1/6/21 around 11:00 PM, one week post 1st  dose Moderna injection, right arm injection site started to itch.  On the morning of 1/7/2021, patient noted site was red, warm and tender to touch.  Reported to RN and MD and observed  erythema approximately 1/2 " circle around injection site, warm to touch with slight swelling. Continues to itch.  Patient was pre-medicated with Benedryl 50 mg. po.
Patient was administered 0.3 ml undiluted pediatric bivalent booster instead of adult bivalent.  Patient experienced normal post-vaccination reaction symptoms including: headache, fever, body aches.  Patient said symptoms were not severe.
Onset of painful/itching papules on dorsum of hands and elbows bilaterally 3-4 days after receiving small pox vaccination, Concern for Eczema Vaccinatum. Denies prior hx of eczema.
Patient presented on 10/6 with a local reaction to ZOSTAVAX. Red, inflamed area, slightly warm to touch. This was 48 hours after vaccine given. No patient harm. F/U in 24 hours to pharmacy.
suspected vaccination failure; I HAD THE SHOT AND STILL GOT THE SHINGLES.; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was selected as adult as per vaccine indication. It was reported that the patient had the shot and still got the shingles. This case was considered as suspected vaccination was failure since the details regarding dose number, time to onset and laboratory confirmation was not reported.
Dizziness.  Her symptoms started 3 days ago when she awakened and felt off balance.  I have done the Dix-Hallpike maneuver and her symptoms do not come on with change in head position.  Does not appear to be an inner ear etiology.  She complains of a left-sided headache, has some gait imbalance with a sensation that she is veering to the left.  I will check orthostatics on her since she has some positional symptoms. Her orthostatics show a blood pressure of 122/82 pulse of 76 lying down, blood pressure 134/85 sitting up with a pulse of 79, standing blood pressure 113/72 with a pulse of 96.  Her pulse does go up 20 points, her blood pressure drops about 10 points.  Her left-sided symptoms are concerning to me with the leaning towards the left that she ambulates and the left-sided headache.  She has had symptoms for 3 days.  I told the patient I would write to rule out any brain pathology.  She will get an urgent CT scan of her brain today.  If that is completely negative, I will need to book her for an urgent MRI. She is booked for a CAT scan  for tomorrow for availability reasons. Copied from my chart Still dealing with vertigo and blood pressure drops. Going to pt and medication for headaches and vertigo and blood pressure.
expired dose; Inappropriate schedule of vaccine administered/ He received his second dose on 03-Feb-2021 and third dose on 12-Oct-2021; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered/ He received his second dose on 03-Feb-2021 and third dose on 12-Oct-2021) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A, 013M20A and 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered/ He received his second dose on 03-Feb-2021 and third dose on 12-Oct-2021). On 12-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered/ He received his second dose on 03-Feb-2021 and third dose on 12-Oct-2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   This case was linked to MOD-2021-350294, MOD-2021-350297, MOD-2021-350305, MOD-2021-350432, MOD-2021-350584 (Patient Link).
Patient developed cellulitis as diagnosed by her physician. Her physician believes it was from the PREVNAR 13 injection on 7/27/16. The redness is receding, but not completely yet (as of 8-8-16).
2/12/19 Saw Dr., right arm swelled, itchy and red up to the collarbone area, unsure if cellulitis or vaccine reaction so started on cephalexin. 2/14/19 Went to Hospital because now had blisters along with continued swelling, diagnosed with an Arthus reaction and antibiotics were stopped.
Extreme fatigue lasting 24 hours - so severe that could not ambulate to use the restroom nor to get food/water.  The fatigue did improve however, this is now moderate/severe fatigue that last throughout the entire day - now persisting for 10 days post vaccination.
ACUTE STROKE DUE TO OCCLUSION OF LEFT MIDDLE CEREBRAL ARTERY SUPERIOR CEREBELLAR ARTERY SYNDROME
STOMACH PAIN; DIARRHEA; VOMITING; SORE ARM; HEADACHE; FATIGUE; BODY ACHE; This spontaneous report received from a patient concerned a 75 year old female. The patient's height, and weight were not reported. The patient's past medical history included skin reaction to another vaccine in the past (MMR), and concurrent conditions included thyroid, blood pressure, and cholesterol. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068 expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 14:00 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid for drug used for unknown indication. On 25-MAR-2021, the subject experienced body ache. On 25-MAR-2021, the subject experienced sore arm. On 25-MAR-2021, the subject experienced headache. On 25-MAR-2021, the subject experienced fatigue. On 26-MAR-2021, the subject experienced stomach pain. On 26-MAR-2021, the subject experienced diarrhea. On 26-MAR-2021, the subject experienced vomiting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, and headache, stomach pain, diarrhea, and vomiting on 27-MAR-2021, and sore arm on 08-APR-2021, and the outcome of fatigue was not reported. This report was non-serious. This case, from the same reporter is linked to 20210427911.
This is a spontaneous case, initially received from other health professional (nurse) on 06-Nov-2018, concerning a 22-months-old, male infant. The patient's current condition included asthma. The patient's concomitant medication included SINGULAR for an unknown indication. On 05-Nov-2018, the patient (under 4 years) was administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: thigh, batch number: 252680, expiry date: 30-Jun-2019). At the time of this report, the patient had not reported any adverse events and was being monitored for side-effects and adverse effects. This case is linked to 201805283, due to same reporter. The reporter assessed this case as non-serious.
Information has been received from a medical assistant concerning a 16 year old female patient with no pertinent medical history and no drug reactions/allergies, who in November 2008, was vaccinated with a first dose of GARDASIL (Lot # not reported). The patient's arm hurt for the rest of the day after receiving her first dose of GARDASIL (Lot # not reported). On an unspecified date, the patient was vaccinated with a second dose of GARDASIL (Lot # not reported) and experienced pain in her arm, shakiness, and syncope-like feeling within a few minutes of administration. Her symptoms lasted for the rest of the day. There were no lab diagnosis/studies performed. The patient sought unspecified medical attention. At the time of the report, the patient had recovered. Follow up information has been received from the medical assistant who stated that the patient reporter their or adverse reaction. They no have further information to report. No further information is available.
Area of inflammation in upper left arm, where vaccination was given, oval in shape measuring 6 cm x 8 cm of about 1 cm in height. Severe myalgia throughout my body for the duration of the day into the night. Severe malaise. Severe fatigue. Mild weakness. Mild abdominal pain. Mild disequilibrium. In short I felt like I was coming down with the flu. There was a short lived low grade fever of 99.9 F for about 4 hours of same day. I woke in the morning of 03-21-18 with hearing loss in my right ear with exacerbated tinnitus. All symptoms except inflammation at injection sight and exacerbation of tinnitus resolved by late afternoon of 03-21-18.
Moderna Covid-19 Vaccine EUA given February 16, 2021 followed two days later with left eye irritation that has persisted until now (February 21, 2021
Red spot on arm about 1.5 inch diameter; Sore arm after injection; This spontaneous case was reported by a patient and describes the occurrence of RASH MACULAR (Red spot on arm about 1.5 inch diameter) and VACCINATION SITE PAIN (Sore arm after injection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (Red spot on arm about 1.5 inch diameter) and VACCINATION SITE PAIN (Sore arm after injection). At the time of the report, RASH MACULAR (Red spot on arm about 1.5 inch diameter) and VACCINATION SITE PAIN (Sore arm after injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Reporter contact details(email address) added. Non-sig information.
Son spiked a high fever of 103.0 that night and would let out high pitch screams while sleeping and stiffen up, then fall back asleep. The next day 12/23/2016 he refused to eat he seemed to not be able to get his suck/swallow rhythm, he ate 6oz total for the day and had no wet diapers. His high fever continued until today 12/24/2016 he still has a fever of a constant 101.0 he started drinking his bottle again working his way up to his normal ounces.
Information has been received from a physician concerning a 5 year old male patient, who on unknown date was vaccinated with a dose of MMR II (lot# and route not reported), 0.5ml. The doctor reported that on approximately 16-MAY-2012 ("3 weeks ago") the patient experienced swollen lip, which the doctor believed may be an allergic reaction to gelatin. Also it was reported that at some point after, the patient had surgery that required a gel foam placement which was gelatin based (manufacturer unspecified) and he experienced anaphylaxis. It was also mentioned that the patient was given MMR II 6 weeks apart when he was 1 year old and had no adverse event. At the time of report the patient's status was not reported. The patient sought unspecified medical attention. Upon internal review, surgery and anaphylaxis were determined to be an other important medical event. Additional information has been requested.
Patient started to get swelling and redness and itching of the arm about 3 to 4 hours after immunizations. Guardian stated that the area was very firm 24 hours after vaccination. The area was about 5 inches by 3 inches in erythema and warmth. Child was given some MOTRIN and BENADRYL. Also used cold compress. Started to feel better after 48 hours. Was seen in clinic on 4/30 for the symptoms. Improving symptoms at the time of the doctors visit. Recommended continued BENADRYL and MOTRIN and cold compresses and to watch the redness and swelling if no improvement in 48 to return to clinic.
pt recv vax 18SPE96 devel 3cm raised wheal @ the inj site;lab results indicated negative immunity;no s/s following first dose;
Mild headache 6/12-6/13.  Mild chest pain with chills in middle of night after receiving 2nd dose.  Nausea and fever the next day.  Went to hospital morning after getting vaccine (6/13).  Hospital said it looked like it was  just the vaccination side effects.  Fever resolved on 6/14.
patient was unresponsive on day 10 and expired on 02/15/2022
Information has been received from a healthcare worker referring to multiple unspecified patients of unknown age and gender. Concurrent condition and medical history were not reported. On unknown dates, the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (lot # reported as "K026887", expiration date: 16-DEC-2016 or lot # K005178, expiration date: 10-APR-2016, dose, frequency and route were unknown). The patient's concomitant medication was not reported. No adverse effects reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Physician). The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 07Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 68 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: sulfa" (unspecified if ongoing), notes: known allergies: sulfa. The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: COVID-19 treatment paxlovid from 02Jan2023 to 07Jan2023. The reporter seriousness was reported as non-serious.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information provided, a causal relationship between BNT162b2, BNT162b2 omi ba.4-5, and the reported events Covid -19, drug ineffective cannot be excluded.
Dizziness and extremely cold began within 15 minutes and persisted for 4 hours